Royalty Pharma plc Files 8-K for Financial Reporting
Ticker: RPRX · Form: 8-K · Filed: Feb 11, 2025 · CIK: 1802768
| Field | Detail |
|---|---|
| Company | Royalty Pharma PLC (RPRX) |
| Form Type | 8-K |
| Filed Date | Feb 11, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-k
TL;DR
Royalty Pharma dropped an 8-K on 2/11 for financial updates.
AI Summary
Royalty Pharma plc filed an 8-K on February 11, 2025, to report on its results of operations and financial condition, as well as to file financial statements and exhibits. The filing does not contain specific financial figures or operational details within the provided text, but indicates a standard reporting event.
Why It Matters
This filing serves as an official notification to investors and the public regarding Royalty Pharma's financial performance and condition, which can influence investment decisions.
Risk Assessment
Risk Level: low — This is a routine filing for financial reporting and does not appear to contain any new material information or significant events.
Key Players & Entities
- Royalty Pharma plc (company) — Registrant
- February 11, 2025 (date) — Date of Report
- 110 East 59th Street (location) — Business Address
- New York (location) — City
- 10022 (location) — ZIP Code
- (212) 883-0200 (phone_number) — Business Phone
FAQ
What specific financial information is being reported in this 8-K?
The provided text indicates the filing is for 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits', but does not detail the specific figures within this excerpt.
When was this 8-K filed?
This 8-K was filed on February 11, 2025.
What is the principal executive office address for Royalty Pharma plc?
The principal executive offices are located at 110 East 59th Street, New York, New York, 10022.
What is the company's telephone number?
The company's telephone number is (212) 883-0200.
What is the SIC code for Royalty Pharma plc?
The Standard Industrial Classification (SIC) code for Royalty Pharma plc is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 520 words · 2 min read · ~2 pages · Grade level 10.8 · Accepted 2025-02-11 07:38:36
Key Financial Figures
- $0.0001 — red Class A Ordinary Shares, par value $0.0001 per share RPRX The Nasdaq Stock Mar
Filing Documents
- d929959d8k.htm (8-K) — 25KB
- d929959dex991.htm (EX-99.1) — 268KB
- g929959dsp05a.jpg (GRAPHIC) — 14KB
- g929959dsp05b.jpg (GRAPHIC) — 3KB
- g929959dsp05c.jpg (GRAPHIC) — 2KB
- 0001193125-25-023988.txt ( ) — 467KB
- rprx-20250211.xsd (EX-101.SCH) — 3KB
- rprx-20250211_lab.xml (EX-101.LAB) — 17KB
- rprx-20250211_pre.xml (EX-101.PRE) — 11KB
- d929959d8k_htm.xml (XML) — 3KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press release issued by Royalty Pharma plc, dated February 11, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirement of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. ROYALTY PHARMA PLC Date: February 11, 2025 By: /s/ Terrance Coyne Terrance Coyne Chief Financial Officer